Financial Results Overview

Standalone Financial Performance (FY 2025-26):

  • Total Income: ₹16.98 lakhs (Previous Year: ₹46.87 lakhs)
  • Other Income: ₹16.98 lakhs
  • Total Expenses: ₹136.71 lakhs (Previous Year: ₹83.65 lakhs)
  • Employee Benefits Expense: ₹46.77 lakhs
  • Other Expenses: ₹89.75 lakhs
  • Profit Before Tax: Loss of ₹119.73 lakhs (Previous Year: Profit of ₹19.09 lakhs)
  • Profit for the Period: Loss of ₹119.73 lakhs (Previous Year: Profit of ₹13.61 lakhs)
  • Earnings Per Share (Basic & Diluted): Loss of ₹1.18 per share (Previous Year: Profit of ₹0.45 per share)
  • Paid-up Equity Share Capital: ₹4,802.19 lakhs (Previous Year: ₹300.00 lakhs)

Consolidated Financial Performance (FY 2025-26):

  • Revenue from Operations: ₹984.53 lakhs
  • Other Income: ₹26.92 lakhs
  • Total Income: ₹1,011.45 lakhs
  • Employee Benefits Expense: ₹189.63 lakhs
  • Finance Costs: ₹41.39 lakhs
  • Depreciation and Amortization: ₹15.40 lakhs
  • Depreciation on Right-of-Use Assets: ₹46.16 lakhs
  • Other Expenses: ₹203.79 lakhs
  • Profit Before Tax: ₹109.40 lakhs
  • Tax Expense: ₹19.01 lakhs (Deferred tax)
  • Profit for the Period: ₹90.38 lakhs
  • Attributable to Owners of Parent: ₹70.24 lakhs
  • Attributable to Non-controlling Interests: ₹20.14 lakhs
  • Total Comprehensive Income: ₹91.11 lakhs
  • Earnings Per Share (Basic & Diluted): ₹0.69 per share

Balance Sheet Position (as at March 31, 2026)

Standalone:

  • Total Assets: ₹6,836.88 lakhs (Previous Year: ₹358.96 lakhs)
  • Non-current Assets: ₹6,078.23 lakhs (primarily Investments)
  • Current Assets: ₹758.65 lakhs
  • Cash and Cash Equivalents: ₹1.51 lakhs (Previous Year: ₹270.56 lakhs)
  • Total Equity and Liabilities: ₹6,836.88 lakhs
  • Equity Share Capital: ₹4,802.19 lakhs
  • Other Equity: ₹997.26 lakhs

Consolidated:

  • Total Assets: ₹14,062.40 lakhs
  • Property, Plant and Equipment: ₹2,381.28 lakhs
  • Right-of-Use Assets: ₹3,989.13 lakhs
  • Goodwill: ₹2,032.27 lakhs
  • Other Intangible Assets: ₹801.71 lakhs
  • Investments: ₹13.25 lakhs
  • Cash and Cash Equivalents: ₹234.59 lakhs
  • Total Equity: ₹6,306.70 lakhs
  • Equity Share Capital: ₹4,802.19 lakhs
  • Other Equity: ₹1,187.90 lakhs
  • Non-controlling Interests: ₹316.62 lakhs
  • Non-current Liabilities: ₹4,488.81 lakhs
  • Current Liabilities: ₹3,266.88 lakhs

Acquisition of Subsidiaries

During the year ended March 31, 2026, the company acquired 100% equity share capital of three entities with effect from March 4, 2026:

1. Health Secure Hospitals Private Limited (HSHPL)

  • Purchase Consideration: ₹29,40,24,587.00
  • 10,63,423 equity shares acquired
  • Consideration: 66% via share swap (allotment of 1,55,21,967 equity shares at ₹12.50 per share) and 34% cash payment

2. Arvaya Health and Wellness Private Limited (AHWPL)

  • Purchase Consideration: ₹18,74,99,875.00
  • 14,99,999 equity shares acquired
  • Consideration: Fully via share swap (allotment of 1,49,99,990 equity shares at ₹12.50 per share)

3. Tec-Pool Solutions Private Limited (TPSPL)

  • Purchase Consideration: ₹12,49,98,487.00
  • 10,000 equity shares acquired
  • Consideration: Fully via share swap (allotment of 99,99,879 equity shares at ₹12.50 per share)

Total Purchase Consideration: ₹60,65,22,950.00

Goodwill Recognition

Provisional goodwill of ₹20,32,26,741 recognized on acquisition of subsidiaries:

  • HSHPL (including step-down subsidiary): ₹6,18,21,934
  • AHWPL: ₹1,57,74,513
  • TPSPL: ₹12,56,30,294

Corporate Developments

Change of Company Name

  • Name changed from "Bijoy Hans Limited" to "Arvaya Healthcare Limited" effective May 11, 2026
  • Change occurred after reporting date (non-adjusting event per Ind AS 10)

Increase in Authorized Share Capital

  • Authorized Share Capital increased from ₹60 crores to ₹200 crores
  • Approved by Board on March 17, 2026 and shareholders on April 19, 2026

Contingent Liabilities

  • Litigation/arbitration proceedings against the company with claims of ₹37,217.42 thousands
  • Company deposited ₹16,774.63 thousands with Registrar of City Civil Courts during FY 2021-22
  • Commercial Court judgment in company's favor during FY 2022-23, but appeal pending in High Court
  • Management believes probability of favorable outcome is high

Cash Flow Information (Consolidated)

  • Net Cash from Operating Activities: Negative ₹327.56 lakhs
  • Net Cash from Investing Activities: Negative ₹694.45 lakhs
  • Net Cash from Financing Activities: Positive ₹752.96 lakhs
  • Net Decrease in Cash: Negative ₹269.05 lakhs
  • Cash and Cash Equivalents at Year End: ₹234.59 lakhs

#Tags: #ArvayaHealthcare #FY26Results #SEBIDisclosure #FinancialCorrigendum #HealthcareAcquisition #Neutral